Systemic lupus erythematosus and antiphospholipid syndrome

0Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Antiphospholipid syndrome is an autoimmune disorder defined as association of vascular thrombosis and/or pregnancy complications with presence of antiphospholipid antibodies (lupus anticoagulant, anticardiolipin and anti-β2 glycoprotein I). It is the most common cause of acquired thrombophilia, and can occur as an independent entity or in relation with other diseases, especially systemic lupus erythematosus. Presence of antiphospholipid syndrome in systemic lupus erythematosus is additional vaso occlusive factor in already present inflammation, bringing further risk for thrombotic events. Clinical and serological manifestations of antiphospholipid syndrome and systemic lupus erythematosus are very similar, so possible connection for these two autoimmune disorders is assumed.

Cite

CITATION STYLE

APA

Plavsic, A., Miskovic, R., Raskovic, S., Bogic, M., & Nikolic, B. B. (2014). Systemic lupus erythematosus and antiphospholipid syndrome. Macedonian Journal of Medical Sciences, 7(3), 544–549. https://doi.org/10.3889/MJMS.1857-5773.2014.0437

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free